Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Fingolimod is a potential novel therapy for multiple sclerosis.
BG00012 and Disability Progression in Secondary Progressive Multiple Sclerosis (SPMS) (INSPIRE)
URMC rheumatologist presents data showing drug’s potential to ease arthritis symptoms
Pathological mechanisms in progressive multiple sclerosis.
Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).
Food and Drug Administration drug insert for Campath (alemtuzumab)
Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains.
CHMP adopts positive opinion for PLEGRIDY™ (peginterferon beta-1a) as a treatment for multiple sclerosis in the European Union
Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1.
FTY720/Fingolimod, a Sphingosine Analogue, Reduces Amyloid-β Production in Neurons.
Efficacy and Tolerability of BAF312 in Patients With Polymyositis
Selective inhibition of CCR7- TEM cells activation by a novel peptide targeting Kv1.3 in a rat EAE model.
Mitoxantrone-induced suicidal erythrocyte death.
Uhthoff's phenomena in MS-clinical features and pathophysiology.
Adeona and the Skirball Foundation Join Forces to Advance Multiple Sclerosis Research
Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study.
Physicians from Accentia and Johns Hopkins University present plans for new MS drug study for Cyrevia
Impact of sleep disorder treatment on fatigue in multiple sclerosis.
Subcutaneous IFN-β1a to treat relapsing-remitting multiple sclerosis.
European Medicines Agency
Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient- and physician-reported outcomes in relapsing multiple sclerosis: post hoc analyses of the EPOC trial.
Antiinflammatory effects of orientin-2″-o-galactopyranoside on lipopolysaccharide-stimulated microglia.
Discontinuation of Disease-Modifying Treatment for Multiple Sclerosis
Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1.
Increased Serum Brain-derived Neurotrophic Factor in Multiple Sclerosis Patients on Interferon-β and Its Impact on Functional Abilities.

Pages